Literature DB >> 31810518

Minimally invasive sigmoidectomy for diverticular disease decreases inpatient opioid use: Results of a propensity score-matched study.

Amir L Bastawrous1, I-Fan Shih2, Yanli Li2, Robert K Cleary3.   

Abstract

BACKGROUND: Patients undergoing gastrointestinal surgery are at high risk for postoperative opioid use.
METHODS: We evaluated inpatient opioid use among patients undergoing sigmoidectomy for diverticular disease from the Premier Hospital Database and compared across surgical approaches using propensity score-matching analysis.
RESULTS: After the day of surgery, minimally invasive (MIS) patients were administered significantly lower doses of parenteral opioids (median daily morphine milligram equivalents [MME]: 33.3 versus 48.3, p < 0.001). Within MIS, significantly less parenteral opioids were used by the robotic-assisted (RS) than the laparoscopic (LS) group (median daily MME: 30.0 versus 36.8, p = 0.012). MIS patients were more likely than open to start oral opioids on the day of surgery (MIS vs. OS: 8.7% vs. 6.6%, p < 0.001; RS vs. LS: 12.6% vs. 10.2%, p = 0.048).
CONCLUSION: Minimally invasive sigmoidectomy for diverticular disease was associated with less postoperative parenteral opioid use and starting oral opioids sooner after surgery compared to the open approach.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diverticulitis; Diverticulosis; Minimally invasive surgery; Opioids; Robotic-assisted; Sigmoidectomy

Year:  2019        PMID: 31810518     DOI: 10.1016/j.amjsurg.2019.11.030

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

1.  Analysis of Opioid Use in Patients Undergoing Open Versus Robotic Gastrectomy.

Authors:  Yuki Hirata; Russell G Witt; Laura R Prakash; Elsa M Arvide; Kristen A Robinson; Vijaya Gottumukkala; Ching-Wei D Tzeng; Paul Mansfield; Brian D Badgwell; Naruhiko Ikoma
Journal:  Ann Surg Oncol       Date:  2022-05-04       Impact factor: 4.339

2.  Comparison of health-care utilization and expenditures for minimally invasive vs. open colectomy for benign disease.

Authors:  Sarah E Diaz; Yongjin F Lee; Amir L Bastawrous; I-Fan Shih; Shih-Hao Lee; Yanli Li; Robert K Cleary
Journal:  Surg Endosc       Date:  2022-02-22       Impact factor: 3.453

3.  A national database propensity score-matched comparison of minimally invasive and open colectomy for long-term opioid use.

Authors:  Amir L Bastawrous; Kara K Brockhaus; Melissa I Chang; Gediwon Milky; I-Fan Shih; Yanli Li; Robert K Cleary
Journal:  Surg Endosc       Date:  2021-02-10       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.